• AI Pickup
  • menu
  • U.S. Stock Market Prediction
    • U.S. Stock Forecast Tomorrow
    World Stock Markets
  • ETF Market Prediction
    • ETF Forecast Tomorrow
  • Cryptocurrency Prediction
  • Forex Market Prediction
  • Sign In Sign Up
  • AI Pickup logo
  • U.S. Stock Market Prediction U.S. Stock Forecast Tomorrow World Stock Markets
  • Featured and All ETFs ETF Forecast Tomorrow
  • Featured and All Cryptocurrencies
  • Featured and All Forex
  • Sign In Sign Up
By Wall Street
Price forecast
Financial Info
  • AI Pickup logo
  • U.S. Stock Market Prediction U.S. Stock Forecast Tomorrow World Stock Markets
  • Featured and All ETFs ETF Forecast Tomorrow
  • Featured and All Cryptocurrencies
  • Featured and All Forex
  • Sign In Sign Up
By Wall Street
Price forecast
Financial Info
Quick Access Forecast in this page:
Wall street
Forecast
    You are here:
  • Home
  • USA stock market prediction
  • XLRN stock forecast

XLRN : Acceleron Pharma stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)

The 15 Wall Street analysts offering Acceleron Pharma stock forecast in the last 6 months have average price target of $150.0 with a high forecast of $200.0 and a low forecast of $130.0. The average Acceleron Pharma stock forecast represents a 18.25% increase from the last price of $126.85. From AI system, total return is 2022.2% from 1610 forecasts. For Acceleron Pharma stock forecast 2021, 8 predictions are offered for each month of 2021 with average Acceleron Pharma stock forecast of $125.64, a high forecast of $127.04, and a low forecast of $123.39. The average Acceleron Pharma stock forecast 2021 represents a -0.95% decrease from the last price of $126.85. For Acceleron Pharma stock forecast 2022, 12 predictions are offered for each month of 2022 with average Acceleron Pharma stock forecast of $107.69, a high forecast of $120.86, and a low forecast of $92.75. The average Acceleron Pharma stock forecast 2022 represents a -15.1% decrease from the last price of $126.85. For Acceleron Pharma stock forecast 2025, 12 predictions are offered for each month of 2025 with average Acceleron Pharma stock forecast of $75.31, a high forecast of $77.93, and a low forecast of $74.57. The average Acceleron Pharma stock forecast 2025 represents a -40.63% decrease from the last price of $126.85. For Acceleron Pharma stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Acceleron Pharma stock forecast of $73.9, a high forecast of $74.34, and a low forecast of $73.75. The average Acceleron Pharma stock forecast 2026 represents a -41.74% decrease from the last price of $126.85. For Acceleron Pharma stock forecast 2030, 12 predictions are offered for each month of 2030 with average Acceleron Pharma stock forecast of $188.7, a high forecast of $200.52, and a low forecast of $173.52. The average Acceleron Pharma stock forecast 2030 represents a 48.76% increase from the last price of $126.85. For Acceleron Pharma stock forecast 2031 (10 year), 4 predictions are offered for each month of 2031 with average Acceleron Pharma stock forecast of $203.59, a high forecast of $204.23, and a low forecast of $202.45. The average Acceleron Pharma stock forecast 2031 represents a 60.5% increase from the last price of $126.85. Please, see more forecasts below.

subject
Average
Low
High
Change from close on 2021-04-09
XLRN : Acceleron Pharma stock forecast
$150.0
$130.0
$200.0
18.25%
XLRN : Acceleron Pharma stock forecast 2021
$125.64
$123.39
$127.04
-0.95%
XLRN : Acceleron Pharma stock forecast 2022
$107.69
$92.75
$120.86
-15.1%
XLRN : Acceleron Pharma stock forecast 2023
$82.33
$78.15
$90.3
-35.1%
XLRN : Acceleron Pharma stock forecast 2024
$78.78
$78.06
$79.39
-37.9%
XLRN : Acceleron Pharma stock forecast 2025
$75.31
$74.57
$77.93
-40.63%
XLRN : Acceleron Pharma stock forecast 2026
$73.9
$73.75
$74.34
-41.74%
XLRN : Acceleron Pharma stock forecast 2027
$76.28
$74.1
$81.03
-39.86%
XLRN : Acceleron Pharma stock forecast 2028
$120.53
$83.95
$154.93
-4.99%
XLRN : Acceleron Pharma stock forecast 2029
$161.55
$156.93
$170.75
27.36%
XLRN : Acceleron Pharma stock forecast 2030
$188.7
$173.52
$200.52
48.76%
XLRN : Acceleron Pharma stock forecast 2031
$203.59
$202.45
$204.23
60.5%

Table of contents

  • Price target by Wall Street
  • Acceleron Pharma stock forecast for upcoming days
  • Long term Acceleron Pharma stock forecast
  • Financial Info
  • Frequently Asked Questions (FAQ)
  • 14 Days Historical Data

Statistics

Statistics from all past Buy/Sell opinions in AI Pickup
Total return : 2022.2 %
Number of direction forecasts : 1610

Click to see the forecast history of all tickers

XLRN : Acceleron Pharma stock forecast Wall Street by analysts

The average Acceleron Pharma stock forecast from last 6 month is $150.0, and this show a 9.12% increase in average from the prior price target of the each prediction. Also, this average forecast of $150.0 represents a 17.55% increase from the past average forecast of $127.6, 6 months ago from 10 wall street analysts.

Date
Firm
current price target
previous price target
current rating
2021-03-23
SVB Leerink
$148.0000
Market Perform
2021-03-22
Goldman Sachs
$132.0000
Neutral
2021-03-12
Wolfe Research
$200.0000
Outperform
2021-03-01
Citigroup
$171.0000
$137.0000
Buy
2021-02-26
SVB Leerink
$148.0000
$138.0000
Outperform
2021-02-26
Piper Sandler
$143.0000
$130.0000
Overweight
2021-02-26
Morgan Stanley
$145.0000
$135.0000
Overweight
2021-01-29
JP Morgan
$153.0000
$133.0000
Overweight
2021-01-19
Raymond James
$160.0000
$155.0000
Strong Buy
2021-01-19
HC Wainwright & Co.
$168.0000
$148.0000
Buy
2020-12-16
Morgan Stanley
$135.0000
$130.0000
Overweight
2020-11-16
Oppenheimer
$131.0000
$120.0000
Outperform
2020-11-06
Morgan Stanley
$130.0000
$125.0000
Overweight
2020-11-06
SVB Leerink
$138.0000
$134.0000
Outperform
2020-11-06
HC Wainwright & Co.
$148.0000
$137.0000
Buy
2020-10-13
Morgan Stanley
$125.0000
$123.0000
Overweight
2020-08-07
Credit Suisse
$135.0000
$134.0000
Outperform
2020-08-07
SVB Leerink
$134.0000
$132.0000
Outperform
2020-07-15
Morgan Stanley
$123.0000
$122.0000
Overweight
2020-06-26
SVB Leerink
$132.0000
$127.0000
Outperform
2020-06-25
Credit Suisse
$134.0000
$123.0000
Outperform
2020-06-02
Citigroup
$137.0000
$136.0000
Buy
2020-05-12
JP Morgan
$118.0000
$108.0000
Overweight
2020-05-12
Oppenheimer
$115.0000
$112.0000
Outperform
2020-05-08
Credit Suisse
$123.0000
$99.0000
Outperform

Acceleron Pharma stock forecast for upcoming days

XLRN forecast chart for short term
Date
Price
Acceleron Pharma stock forecast for 2021-04-12
$123.92
Acceleron Pharma stock forecast for 2021-04-13
$126.70
Acceleron Pharma stock forecast for 2021-04-14
$133.83
Acceleron Pharma stock forecast for 2021-04-15
$135.66
Acceleron Pharma stock forecast for 2021-04-16
$136.27
Acceleron Pharma stock forecast for 2021-04-19
$136.58
Acceleron Pharma stock forecast for 2021-04-20
$138.29
Acceleron Pharma stock forecast for 2021-04-21
$138.32
Acceleron Pharma stock forecast for 2021-04-22
$139.67
Acceleron Pharma stock forecast for 2021-04-23
$143.19

Long term Acceleron Pharma(XLRN) stock forecast for 2021, 2022 (1 year) - 2025, 2026 (5 year) - 2030, and 2031 (10 year)

Forecast for May. 2021 is $127.04 , for Apr. 2022 is $114.16 , for Apr. 2025 is $74.57 , for Apr. 2026 is $73.83 , for Apr. 2030 is $182.07 , and for Apr. 2031 is $203.83.

XLRN long term forecast chart
Date
Price
May. 2021
$127.039099134571
Jun. 2021
$126.917444017646
Jul. 2021
$126.66694462925
Aug. 2021
$126.143172073057
Sep. 2021
$125.324461405369
Oct. 2021
$124.758626202579
Nov. 2021
$124.898473536008
Dec. 2021
$123.385948529605
Jan. 2022
$120.85936281199
Feb. 2022
$118.415196486491
Mar. 2022
$116.229401064365
Apr. 2022
$114.161495591784
May. 2022
$112.202170722861
Jun. 2022
$110.065005666485
Jul. 2022
$107.518180651072
Aug. 2022
$104.62398543601
Sep. 2022
$101.591185758305
Oct. 2022
$98.420427423366
Nov. 2022
$95.4552850009423
Dec. 2022
$92.7519496540649
Jan. 2023
$90.2977855297438
Feb. 2023
$88.0662597737018
Mar. 2023
$86.0777396263175
Apr. 2023
$84.2142498429925
May. 2023
$82.7153964152351
Jun. 2023
$81.6270010645192
Jul. 2023
$80.7050894740745
Aug. 2023
$79.9158299700086
Sep. 2023
$79.2067234466252
Oct. 2023
$78.6522324860086
Nov. 2023
$78.3365128438723
Dec. 2023
$78.1470359740619
Jan. 2024
$78.0647201545118
Feb. 2024
$78.1614569306806
Mar. 2024
$78.2546478696073
Apr. 2024
$78.4492363501498
May. 2024
$78.6652095192143
Jun. 2024
$78.8253448904713
Jul. 2024
$78.9912986029075
Aug. 2024
$79.1885495076335
Date
Price
Sep. 2024
$79.3247291537428
Oct. 2024
$79.3898580199252
Nov. 2024
$79.2395498573821
Dec. 2024
$78.8038383518723
Jan. 2025
$77.9280957556213
Feb. 2025
$76.6348704253869
Mar. 2025
$75.2427150175969
Apr. 2025
$74.5662216673356
May. 2025
$74.6694225900917
Jun. 2025
$74.9318328235194
Jul. 2025
$75.1216386885377
Aug. 2025
$75.1795601226627
Sep. 2025
$75.12006073004
Oct. 2025
$74.9829123758181
Nov. 2025
$74.7921195251757
Dec. 2025
$74.5706021776054
Jan. 2026
$74.3369546548651
Feb. 2026
$74.1180448989437
Mar. 2026
$73.941959352601
Apr. 2026
$73.828303693234
May. 2026
$73.7693343484464
Jun. 2026
$73.7490524031217
Jul. 2026
$73.7557846198787
Aug. 2026
$73.7757619400108
Sep. 2026
$73.81162851019
Oct. 2026
$73.8528321137439
Nov. 2026
$73.9122157487935
Dec. 2026
$73.9945376608474
Jan. 2027
$74.0992556170628
Feb. 2027
$74.2375859170321
Mar. 2027
$74.4285432652785
Apr. 2027
$74.6880169118493
May. 2027
$75.0437582117922
Jun. 2027
$75.4960291427729
Jul. 2027
$75.9899240600734
Aug. 2027
$76.4724381801775
Sep. 2027
$77.0263320754166
Oct. 2027
$77.8110953116394
Nov. 2027
$79.0601317114321
Dec. 2027
$81.0285892436304
Date
Price
Jan. 2028
$83.9492990354584
Feb. 2028
$88.0335673980297
Mar. 2028
$93.4746059060161
Apr. 2028
$100.349600490724
May. 2028
$108.412669881677
Jun. 2028
$117.029809850481
Jul. 2028
$125.659707522352
Aug. 2028
$133.941187083911
Sep. 2028
$141.34901377804
Oct. 2028
$147.359256643447
Nov. 2028
$151.81912786852
Dec. 2028
$154.926524163394
Jan. 2029
$156.933711742582
Feb. 2029
$158.037405370471
Mar. 2029
$158.469522298708
Apr. 2029
$158.581551259547
May. 2029
$158.720911192667
Jun. 2029
$159.117776893614
Jul. 2029
$159.939680033321
Aug. 2029
$161.312443001348
Sep. 2029
$163.232593070501
Oct. 2029
$165.524239654559
Nov. 2029
$168.043258482389
Dec. 2029
$170.745832266285
Jan. 2030
$173.516605538305
Feb. 2030
$176.274852622404
Mar. 2030
$179.09406130005
Apr. 2030
$182.06987169672
May. 2030
$185.271092550921
Jun. 2030
$188.607591360661
Jul. 2030
$191.745986315136
Aug. 2030
$194.342940452247
Sep. 2030
$196.28814289724
Oct. 2030
$197.714008128846
Nov. 2030
$198.954539393261
Dec. 2030
$200.519155307601
Jan. 2031
$202.448176062363
Feb. 2031
$203.87296901329
Mar. 2031
$204.230891429612
Apr. 2031
$203.826397913842

Financial Data for Acceleron Pharma stock

Market Cap
7680754688
Held Percent By Insiders
12.189%
Held Percent By Institutions
89.236%
Sector
Healthcare
Website
http://www.acceleronpharma.com
currency
USD

Forward PE
-78.30247
Enterprise Value
6.854928384E9
Enterprise To Ebitda
-41.936
Enterprise To Revenue
74.089

Average 10 day Volume
341716
Average Volume
358772
Fifty Two Week High
$146.15
Fifty Two Week Low
$85.32

Frequently Asked Questions about Acceleron Pharma stock forecast

Is Acceleron Pharma a good long term stock?

From Acceleron Pharma stock forecast 2021, Acceleron Pharma (XLRN) stock can be a good investment choice. According to AI Pickup, the Acceleron Pharma stock price forecast for May. 2021 is $127.039099134571

From Acceleron Pharma stock forecast 2022, Acceleron Pharma (XLRN) stock cannot be a good investment choice. According to AI Pickup, the Acceleron Pharma stock price forecast for Apr. 2022 is $114.161495591784

From Acceleron Pharma stock forecast 2025, Acceleron Pharma (XLRN) stock cannot be a good investment choice. According to AI Pickup, the Acceleron Pharma stock price forecast for Apr. 2025 is $74.5662216673356

From Acceleron Pharma stock forecast 2026, Acceleron Pharma (XLRN) stock cannot be a good investment choice. According to AI Pickup, the Acceleron Pharma stock price forecast for Apr. 2026 is $73.828303693234

From Acceleron Pharma stock forecast 2030, Acceleron Pharma (XLRN) stock can be a good investment choice. According to AI Pickup, the Acceleron Pharma stock price forecast for Apr. 2030 is $182.06987169672

From Acceleron Pharma stock forecast 2031, Acceleron Pharma (XLRN) stock can be a good investment choice. According to AI Pickup, the Acceleron Pharma stock price forecast for Apr. 2031 is $203.826397913842

Is Acceleron Pharma stock overvalued?

Acceleron Pharma (XLRN) stock is expected to go DOWN . Therefore, AI Pickup would say that Acceleron Pharma (XLRN) stock is overvalued.

Will Acceleron Pharma stock price go up?

No. The Acceleron Pharma stock price forecast for Apr. 2022 is $114.161495591784

Is Acceleron Pharma stock a good buy now?

Since closing price on 2021-04-09 is $126.85 and forecast for Apr. 2022 is $114.16, Acceleron Pharma stock is not a good 1 year investment.

14 Days Historical Data for Acceleron Pharma stock price

Date
Close
Open
Low
High
XLRN stock price for 2021-03-22
$143.64
$137.86
$136.17
$146.15
XLRN stock price for 2021-03-23
$135.99
$139.09
$134.86
$141.68
XLRN stock price for 2021-03-24
$131.8
$136.67
$130.61
$137.21
XLRN stock price for 2021-03-25
$135.74
$131.44
$129.84
$137.3
XLRN stock price for 2021-03-26
$136.61
$136.09
$132.2
$137.09
XLRN stock price for 2021-03-29
$131.46
$135.56
$131.18
$136.85
XLRN stock price for 2021-03-30
$133.01
$131.44
$130.16
$135.51
XLRN stock price for 2021-03-31
$135.61
$133.12
$132.66
$137.95
XLRN stock price for 2021-04-01
$138.03
$137.23
$132.57
$138.4
XLRN stock price for 2021-04-05
$140.02
$139.19
$135.06
$142.72
XLRN stock price for 2021-04-06
$138.62
$138.63
$138.07
$142.15
XLRN stock price for 2021-04-07
$133.0
$139.05
$132.64
$139.05
XLRN stock price for 2021-04-08
$129.32
$134.19
$128.2
$134.42
XLRN stock price for 2021-04-09
$126.85
$129.88
$124.95
$129.88
    • About
    • Company
    • Contact
    • Terms of Use
    • Privacy Policy
    • Risk Warning
    • COPYRIGHT © 2020 - 2021 by AI Pickup. All rights reserved.
    Risk Disclosure: Trading in any financial instruments including but not limited to stocks, ETF, bond, and forex and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount. Past results/performance of AI Pickup should not be any indication of any future results. You should make any investment after consulting your financial advisor and conducting your own research and due diligence. We exclude any and all liability for Our Content. Our Content shall not qualify as investment advice, counseling or any other information serving as a basis of investment (selling, purchasing, etc.) decisions.